Modern pharmacological studies have proven that this drug has a positive therapeutic potential on Alzheimer’s disease, and several alkaloids have been identified as the main AChE inhibitors (Zhao et al., 2016; Cao et al., 2018; Lin et al., 2020a). This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.